Suny Downstate Medical Center, Brooklyn (United States of America)
Follow
Contributor content
Presentation
Impact of zilebesiran, an investigational RNA interference therapeutic targeting hepatic angiotensinogen, on renin-angiotensin system biomarkers in patients with mild-to-moderate hypertension
